Exploring association between MBL2 gene polymorphisms and the occurrence of clinical blackwater fever through a case-control study in Congolese children.

Bodi, Joseph M.; Nsibu, Celestin N.; Longenge, Roland L.; Aloni, Michel N.; Akilimali, Pierre Z.; Kayembe, Patrick K.; Omar, Ahmeddin H.; Verhaegen, Jan; Tshibassu, Pierre M.; Lukusa, Prosper T.; Lumaka Zola, Aimé; Hirayama, Kenji

doi:10.1186/s12936-020-3100-8

Article (Scientific journals)

Exploring association between MBL2 gene polymorphisms and the occurrence of clinical blackwater fever through a case-control study in Congolese children.

Bodi, Joseph M.; Nsibu, Celestin N.; Longenge, Roland L. et al.

2020 • In Malaria Journal, 19 (1), p. 25

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/243864

DOI
10.1186/s12936-020-3100-8

PubMed
31941497

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

s12936-020-3100-8.pdf

Publisher postprint (915.19 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Blackwater fever; Democratic Republic of Congo; MBL2; Mannose-Binding Lectin 2; Severe malaria

Abstract :

[en] BACKGROUND: Blackwater fever (BWF), one of the most severe and life-threatening forms of falciparum malaria, is characterized by acute massive intravascular haemolysis, often leading to acute renal failure. Thus far, the genetics of the underlying susceptibility to develop BWF is not fully elucidated. Deficiency in the MBL protein, an important component of the innate immune system, has previously been suggested to be a susceptibility factor for the development of severe malaria. This study aimed to evaluate the association between MBL2 gene polymorphisms, known to affect the MBL protein level/activity, and the occurrence of BWF among Congolese children. METHODS: This is a case-control study. Cases were patients with BWF, whereas controls, matched for gender and age, had uncomplicated malaria (UM). Dried blood spot was collected for genotyping. RESULTS: A total of 129 children were screened, including 43 BWF and 86 UM. The common allele in BWF and UM was A, with a frequency of 76.7 and 61.0%, respectively (OR: 2.67 (0.87-829) and p = 0.079). The frequency of the C allele was 18.6 and 29.1% in BWF and UM groups, respectively, with p = 0.858. Not a single D allele was encountered. Genotype AA was at higher risk for BWF whereas genotypes A0 (AB and AC) were over-represented in UM group (OR: 0.21 (0.06-0.78)) with p = 0.019. Nine haplotypes were observed in this study: 3 high MBL expression haplotypes and 6 low MBL expression haplotype. One new haplotype HYPC was observed in this study. None of these haplotypes was significantly associated with BWF. CONCLUSION: This pilot study is a preliminary research on MBL2 gene and infectious diseases in DRC. The study results show a higher risk for BWF in AA. This suggests that future studies on BWF should further investigate the contribution of a strong immune response to the occurrence of BWF.

Disciplines :

Laboratory medicine & medical technology

Author, co-author :

Bodi, Joseph M.

Nsibu, Celestin N.

Longenge, Roland L.

Aloni, Michel N.

Akilimali, Pierre Z.

Kayembe, Patrick K.

Omar, Ahmeddin H.

Verhaegen, Jan

Tshibassu, Pierre M.

Lukusa, Prosper T.

Lumaka Zola, Aimé ; Université de Liège - ULiège > Cancer-Human Genetics

Hirayama, Kenji

Language :

English

Title :

Exploring association between MBL2 gene polymorphisms and the occurrence of clinical blackwater fever through a case-control study in Congolese children.

Publication date :

2020

Journal title :

Malaria Journal

eISSN :

1475-2875

Publisher :

BioMed Central, United Kingdom

Volume :

Issue :

Pages :

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 22 January 2020

Statistics

Number of views

57 (1 by ULiège)

Number of downloads

42 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Naito H, Ikeda A, Hasegawa K, Oka S, Uemura K, Kawasaki N, et al. Characterization of human serum mannan-binding protein promoter. J Biochem. 1999;126:1004-12.
Giubergia V, Salim M, Fraga J, Castiglioni N, Sen L, Castanos C, et al. Post-infectious bronchiolitis obliterans and mannose-binding lectin insufficiency in Argentinean children. Respirology. 2015;20:982-6.
Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, et al. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics. 1994;40:37-44.
Sumiya M, Super M, Tabona P, Levinsky RJ, Arai T, Turner MW, et al. Molecular basis of opsonic defect in immunodeficient children. Lancet. 1991;337:1569-70.
Lipscombe RJ, Sumiya M, Hill AV, Lau YL, Levinsky RJ, Summerfield JA, et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet. 1992;1:709-15.
Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO. Mannose-binding lectin and its genetic variants. Genes Immun. 2006;7:85.
Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 1998;11:1-3.
Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2003;37:1496-505.
Madsen HO, Garred P, Thiel S, Kurtzhals JA, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155:3013-20.
Jha AN, Sundaravadivel P, Singh VK, Pati SS, Patra PK, Kremsner PG, et al. MBL2 variations and malaria susceptibility in Indian populations. Infect Immun. 2014;82:52-61.
Mhandire K, Pharo G, Kandawasvika GQ, Duri K, Swart M, Stray-Pedersen B, et al. How does mother-to-child transmission of HIV differ among African populations? Lessons from MBL2 genetic variation in Zimbabweans. OMICS. 2014;18:454-60.
Bodi JM, Nsibu CN, Longenge RL, Aloni MN, Akilimali PZ, Tshibassu PM, et al. Blackwater fever in Congolese children: a report of clinical, laboratory features and risk factors. Malar J. 2013;12:205.
Delacollette C, Taelman H, Wery M. An etiologic study of hemoglobinuria and blackwater fever in the Kivu Mountains, Zaire. Ann Soc Belg Med Trop. 1995;75:51-63.
Ministère du Plan et Suivi de la Mise en Oeuvre de la Révolution et de la Modernité Modernité, Ministère de la Santé Publique. Enquête Démographique et de la Santé. République Démocratique du Congo, 2013.
Mokoli MV, Nseka MN, Lepira FB, Sumaili EK, Bukabau J. Profil clinico-bio-morphologique et évolutif de l'insuffisance rénale aiguë aux Cliniques Universitaires de Kinshasa. Annales Africaines de Médecine. 2007;1:11-9.
Nebie I, Diarra A, Ouedraogo A, Soulama I, Bougouma EC, Tiono AB, et al. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. Infect Immun. 2008;76:759-66.
Aloni MN, Nsibu CN, Meeko-Mimaniye M, Ekulu PM, Bodi JM. Acute renal failure in Congolese children: a tertiary institution experience. Acta Paediatr. 2012;101:e514-8.
Assounga AG, Assambo-Kieli C, Mafoua A, Moyen G, Nzingoula S. Etiology and outcome of acute renal failure in children in congo-brazzaville. Saudi J Kidney Dis Transpl. 2000;11:40-3.
Bruneel F, Gachot B, Wolff M, Bedos JP, Regnier B, Danis M, et al. Blackwater fever. Presse Med. 2002;31:1329-34 (in French).
Das BS. Renal failure in malaria. J Vector Borne Dis. 2008;45:83-97.
Kunuanunua TS, Nsibu CN, Gini-Ehungu JL, Bodi JM, Ekulu PM, Situakibanza H, et al. Acute renal failure and severe malaria in Congolese children living in Kinshasa, Democratic Republic of Congo. Nephrol Ther. 2013;9:160-5 (in French).
Daubrey-Potey T, Die-Kacou H, Kamagate M, Vamy M, Balayssac E, Yavo JC. Blackwater fever during antimalarial treatment in Abidjan (West Africa): report of 41 cases. Bull Soc Pathol Exot. 2004;97:325-8 (in French).
Garred P, Nielsen MA, Kurtzhals JA, Malhotra R, Madsen HO, Goka BQ, et al. Mannose-binding lectin is a disease modifier in clinical malaria and may function as opsonin for Plasmodium falciparum-infected erythrocytes. Infect Immun. 2003;71:5245-53.
Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol. 1998;161:3169-75.
WHO Group. Guidelines for the Treatment of Malaria. 3rd ed. Geneva: World Health Organization; 2015.
Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods. 2000;241:33-42.
Casanova JL, Abel L. Human Mannose-binding Lectin in Immunity: friend, Foe, or Both? J Exp Med. 2004;199:1295-9.
Garred P, Madsen HO, Balslev U, Hofmann B, Pedersen C, Gerstoft J, et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet. 1997;349:236-40.
Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet. 1995;346:941-3.
Gordon AC, Waheed U, Hansen TK, Hitman GA, Garrard CS, Turner MW, et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock. 2006;25:88-93.
Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum. 1996;39:2046-51.
Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Monteil MA, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet. 1995;345:886-9.
Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. BMJ. 1997;314:1229-32.
Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, Svejgaard A. Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol. 1992;90:517-21.
Takahashi K, Gordon J, Liu H, Sastry KN, Epstein JE, Motwani M, et al. Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect. 2002;4:773-84.
Bodi J, Nsibu C, Longenge R, Aloni M, Akilimali P, Tshibassu P, et al. High IgG1 malaria antibodies level in children is a possible risk factor of blackwater fever: a case-control study. Pediatr Health Res. 2018;3:9.
Monsey L, Best LG, Zhu J, DeCroo S, Anderson MZ. The association of mannose binding lectin genotype and immune response to Chlamydia pneumoniae: the Strong Heart Study. PLoS ONE. 2019;14:e0210640.
Assoumanou MG, Akpona SA. Dosage de l'hémoglobine urinaire par un réactif 3,3′ diméthylbenzidine: mise au point technique. Int J Biol Chem Sci. 2011;5:11.
Dean FB, Nelson JR, Giesler TL, Lasken RS. Rapid amplification of plasmid and phage DNA using Phi 29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res. 2001;11:1095-9.
Gobbi F, Audagnotto S, Trentini L, Nkurunziza I, Corachan M, Di Perri G. Blackwater fever in children, Burundi. Emerg Infect Dis. 2005;11:1118-20.
Bouldouyre MA, Dia D, Carmoi T, Fall KB, Chevalier B, Debonne JM. A mild blackwater fever. Med Mal Infect. 2006;36:343-5 (in French).
Khandelwal V, Udawat H, Kumhar MR, Goyal RK. Blackwater fever treated with artemether. J Assoc Physicians India. 2001;49:1191-2.
Rogier C, Imbert P, Tall A, Sokhna C, Spiegel A, Trape JF. Epidemiological and clinical aspects of blackwater fever among African children suffering frequent malaria attacks. Trans R Soc Trop Med Hyg. 2003;97:193-7.
Tran TH, Day NP, Ly VC, Nguyen TH, Pham PL, Nguyen HP, et al. Blackwater fever in southern Vietnam: a prospective descriptive study of 50 cases. Clin Infect Dis. 1996;23:1274-81.
WHO. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J. 2012;2012(11):424.
Bellamy R, Ruwende C, McAdam KP, Thursz M, Sumiya M, Summerfield J, et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. QJM. 1998;91:13-8.
Bernig T, Taylor JG, Foster CB, Staats B, Yeager M, Chanock SJ. Sequence analysis of the mannose-binding lectin (MBL2) gene reveals a high degree of heterozygosity with evidence of selection. Genes Immun. 2004;5:461-76.
Boldt AB, Messias-Reason IJ, Meyer D, Schrago CG, Lang F, Lell B, et al. Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet. 2010;11:38.
Verdu P, Barreiro LB, Patin E, Gessain A, Cassar O, Kidd JR, et al. Evolutionary insights into the high worldwide prevalence of MBL2 deficiency alleles. Hum Mol Genet. 2006;15:2650-8.
Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics. 1992;48:361-72.
Garred P, Harboe M, Oettinger T, Koch C, Svejgaard A. Dual role of mannan-binding protein in infections: another case of heterosis? Eur J Immunogenet. 1994;21:125-31.
Garred P, Madsen HO, Halberg P, Petersen J, Kronborg G, Svejgaard A, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum. 1999;42:2145-52.
Hoal-Van Helden EG, Epstein J, Victor TC, Hon D, Lewis LA, Beyers N, et al. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res. 1999;45(4 Pt 1):459-64.
Santos IK, Costa CH, Krieger H, Feitosa MF, Zurakowski D, Fardin B, et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun. 2001;69:5212-5.
Boldt AB, Petzl-Erler ML. A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat. 2002;19:296-306.
Sher A, Ed. Hemoglobinuria (Black Water Fever) in severe falciparum malaria - a case report. In: 17th International Congress on Infectious Diseases; 2016.
Lon C, Spring M, Sok S, Chann S, Bun R, Ittiverakul M, et al. Blackwater fever in an uncomplicated Plasmodium falciparum patient treated with dihydroartemisinin-piperaquine. Malar J. 2014;13:96.
Rodriguez-Valero N, Castro P, Martinez G, Marco Hernandez J, Fernandez S, Gascon J, et al. Blackwater fever in a non-immune patient with Plasmodium falciparum malaria after intravenous artesunate. J Travel Med. 2018;25:e101093.